ZA200807024B - Alpha crystaline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it - Google Patents

Alpha crystaline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it

Info

Publication number
ZA200807024B
ZA200807024B ZA200807024A ZA200807024A ZA200807024B ZA 200807024 B ZA200807024 B ZA 200807024B ZA 200807024 A ZA200807024 A ZA 200807024A ZA 200807024 A ZA200807024 A ZA 200807024A ZA 200807024 B ZA200807024 B ZA 200807024B
Authority
ZA
South Africa
Prior art keywords
perindopril
alpha
preparing
pharmaceutical compositions
arginine salt
Prior art date
Application number
ZA200807024A
Other languages
English (en)
Inventor
Gerard Coquerel
Loic Lefebver
Jean-Claude Souvie
Pascale Authouart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37022969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200807024(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of ZA200807024B publication Critical patent/ZA200807024B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200807024A 2006-02-28 2007-02-26 Alpha crystaline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it ZA200807024B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0601748A FR2897866B1 (fr) 2006-02-28 2006-02-28 Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
ZA200807024B true ZA200807024B (en) 2010-04-28

Family

ID=37022969

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807024A ZA200807024B (en) 2006-02-28 2007-02-26 Alpha crystaline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it

Country Status (28)

Country Link
US (1) US7846961B2 (pt)
EP (1) EP1989182B1 (pt)
JP (1) JP5255454B2 (pt)
KR (2) KR20120001818A (pt)
CN (1) CN101389603B (pt)
AU (1) AU2007220435B2 (pt)
BR (1) BRPI0708278B8 (pt)
CA (1) CA2644467C (pt)
CY (1) CY1117753T1 (pt)
DK (1) DK1989182T3 (pt)
EA (1) EA014716B1 (pt)
ES (1) ES2581982T3 (pt)
FR (1) FR2897866B1 (pt)
GE (1) GEP20125433B (pt)
HK (1) HK1129669A1 (pt)
HR (1) HRP20160644T1 (pt)
HU (1) HUE027898T2 (pt)
MA (1) MA30276B1 (pt)
ME (1) ME02456B (pt)
MY (1) MY151035A (pt)
NO (1) NO20083535L (pt)
NZ (1) NZ570367A (pt)
PL (1) PL1989182T3 (pt)
RS (1) RS54754B1 (pt)
SI (1) SI1989182T1 (pt)
UA (1) UA89905C2 (pt)
WO (1) WO2007099217A1 (pt)
ZA (1) ZA200807024B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2318365B1 (en) 2008-06-24 2015-08-12 Mylan Laboratories Limited Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina
CN114149357B (zh) * 2021-12-29 2024-06-25 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP2318365B1 (en) 2008-06-24 2015-08-12 Mylan Laboratories Limited Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof

Also Published As

Publication number Publication date
EA200801777A1 (ru) 2009-02-27
CN101389603A (zh) 2009-03-18
CY1117753T1 (el) 2017-05-17
US7846961B2 (en) 2010-12-07
EP1989182A1 (fr) 2008-11-12
PL1989182T3 (pl) 2016-09-30
EP1989182B1 (fr) 2016-04-13
NO20083535L (no) 2008-08-14
DK1989182T3 (en) 2016-07-25
JP5255454B2 (ja) 2013-08-07
HUE027898T2 (en) 2016-10-28
ME02456B (me) 2017-02-20
AU2007220435B2 (en) 2010-11-04
GEP20125433B (en) 2012-03-26
FR2897866B1 (fr) 2008-04-18
JP2009534295A (ja) 2009-09-24
US20090203758A1 (en) 2009-08-13
KR20080106948A (ko) 2008-12-09
BRPI0708278B1 (pt) 2021-03-02
CA2644467A1 (fr) 2007-09-07
UA89905C2 (ru) 2010-03-10
CA2644467C (fr) 2011-07-26
HK1129669A1 (pt) 2009-12-04
FR2897866A1 (fr) 2007-08-31
WO2007099217A1 (fr) 2007-09-07
KR20120001818A (ko) 2012-01-04
HRP20160644T1 (hr) 2016-07-01
AU2007220435A1 (en) 2007-09-07
SI1989182T1 (sl) 2016-07-29
MY151035A (en) 2014-03-31
MA30276B1 (fr) 2009-03-02
EA014716B1 (ru) 2011-02-28
BRPI0708278A2 (pt) 2011-05-24
ES2581982T3 (es) 2016-09-08
RS54754B1 (sr) 2016-10-31
NZ570367A (en) 2011-03-31
CN101389603B (zh) 2012-07-04
BRPI0708278B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
ZA200807024B (en) Alpha crystaline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it
IL214236A0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
IL215065A (en) Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation
SI1752443T1 (sl) Nova kristalinična oblika V agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo
IL203142A (en) Anti-B antibody CD79, pharmaceuticals including them, their use and method of preparation
HK1164050A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
IL196280A0 (en) Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
ME02689B (me) Novi kristalni oblik iii agomelatina, postupak za njegovu pripremu i farmaceutski preparati istog
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
EP2429987A4 (en) AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
IL211018A (en) Inhibitors, processes for making them, medicinal preparations containing them and their use
IL218370A0 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen, processes for producing the same and uses thereof
IL218539A (en) Annotated 4,1-Androsteadian-3-Oxo-9,6-Dihlo-16-Isoxazolidine-17-Noble N-Converted
HUP0600808A2 (en) New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0600293A2 (en) Zinc salt of rosuvastatine, process for its preparation and pharmaceutical compositions containing it
PT2231598E (pt) Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham
EP2361907A4 (en) THE FIVE CRYSTALLINE FORMS OF NICOUSAMIDE, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
EP2212325A4 (en) 2-ARYLMETHYLAZETIDINCARBAPENEM-3-CARBOXYLENE DERTERIVATE OR SALT, METHOD FOR THE PRODUCTION THEREOF AND THEREOF COMPRISING PHARMACEUTICAL COMPOSITION
ZA200902414B (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL190230A0 (en) Derivatives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
EP2222624A4 (en) 4-NEROLIDYLCATECHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THESE DERIVATIVES AND PREPARATION METHOD THEREOF
HUP0700782A3 (en) Novel peptides and amino acid derivatives, pharmaceutical compositions containing the same and use of the compounds
ZA200902413B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
EP2629767A4 (en) BENZENE-SULFONANILIDE AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND METHOD OF TREATING CANCER USING SAME
HU0900281D0 (en) Kynurenc acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use for the treatment of headache